Description
Tesamorelin is a modified peptide used or investigated in visceral-adiposity and gh-axis research. Its principal scientific rationale involves ghrh receptor agonist. Product identity, purity, counterion, water content, sterility and stability must be established using qualified specifications and lot-specific analytical testing. Regulatory and clinical status should be independently reviewed before any commercial or human-use decision.
| Mechanism of Action | Primary Research Applications | CAS Number | Molecular Formula | Molecular Weight (g/mol) | IUPAC / Sequence Definition | Material Class | Form / Appearance |
| GHRH receptor agonist | Visceral-adiposity and GH-axis research | 218949-48-5 | C221H366N72O67S | 5135.98 | N-terminally modified human GHRH(1-44) | Modified peptide | White to off-white lyophilized cake/powder |




